Verrica Pharmaceuticals (VRCA)

• Market cap: $44.9M
• 1 day: 4.57%
• 5 days: 4.61%
• 1 month: 15.41%
• 3 months: -24.29%
• 6 months: -68.27%
• Year to date: -30.91%
• 1 year: -92.91%
• 5 years: -95.58%
• 10 years: -97.23%
• Sector: Healthcare
• Industry: Biotechnology

About: Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.

Employees: 71

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

22% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 18

18% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 17

1% more funds holding

Funds holding: 79 [Q3] → 80 (+1) [Q4]

3% less capital invested

Capital invested by funds: $21.6M [Q3] → $20.9M (-$638K) [Q4]

1.86% less ownership

Funds ownership: 34.91% [Q3] → 33.05% (-1.86%) [Q4]

50% less call options, than puts

Call options by funds: $2K | Put options by funds: $4K